Becton, Dickinson and Company, BD Biosciences 2022-06-08 Health serious FDA
Health · FDA · Recall #FDA-Z-1215-2022
BD Anti-Kappa PE (Cat. No. 346587) is an analyte specific reagent for the Anti-Kappa… Recall
Issued June 8, 2022 · Becton, Dickinson and Company, BD Biosciences
In June 2022, Becton, Dickinson and Company, BD Biosciences recalled the BD Anti-Kappa PE (Cat. No. 346587) is an analyte specific reagent for the Anti-Kappa…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Anti-Kappa APC & Anti-Kappa PE analyte reagents may exhibit uncharacteristic flow profiles.
What you should do
- 1 Stop using BD Anti-Kappa PE (Cat. No. 346587) is an analyte specific reagent for the Anti-Kappa… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Becton, Dickinson and Company, BD Biosciences to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Becton, Dickinson and Company, BD Biosciences
- Category
- Health
- Recall date
- June 8, 2022
- Units affected
- Not reported
- Sold at
- Worldwide distribution - US Nationwide distribution in the states of AL, CA, CO, DC, DE, FL, IA, IL, IN, LA, MA, MD, ME, MI, MN, MO, NC, ND,
- Recall number
- FDA-Z-1215-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Becton, Dickinson and Company, BD Biosciences has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.